Sweet-Tasting Solution Versus Placebo to Reduce Pain During Local Anesthetic Injection in Children
NCT ID: NCT07279285
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
54 participants
INTERVENTIONAL
2026-01-01
2026-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
Does SFSS reduce pain during dental local anesthesia compared to a placebo (plain water)? Researchers will compare the use of SFSS and a placebo to see which results in lower pain scores.
Participants will:
Receive SFSS or placebo before local anesthesia during two dental visits Have their pain measured using self-reported and observational pain scales Have their heart rate monitored during the procedure
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Candy Flavoring Before Local Anesthesia on Anxiety and Pain Perception in Children
NCT05727527
Be Sweet to Toddlers: Does Sugar Water Reduce Pain During Blood Work?
NCT02151136
The Effectiveness of Sweet Solution Versus Cryotherapy in Reducing Pain During Administration of Local Anesthesia Among Children
NCT07002528
Effect on Pain of Oral Sucrose Versus Placebo in Children 1 to 3 Months Old Needing Venipuncture
NCT01293812
Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Bladder Catheterization
NCT01544985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sugar-free-flavored sweet tasting solution Group
Sugar-free-flavored sweet tasting solution
A sugar-free-flavored sweet tasting solution that is anticipated to reduce the pain of local anaesthesia injections
Placebo Group
Placebo (sterile-water)
Placebo (sterile water)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sugar-free-flavored sweet tasting solution
A sugar-free-flavored sweet tasting solution that is anticipated to reduce the pain of local anaesthesia injections
Placebo (sterile-water)
Placebo (sterile water)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Children classified as ASA1 according to the American Society of Anesthesiologists.
3. Children who have positive (Class III) or definitely positive (Class IV) behavior during preoperative behavioral assessments according to the Frankl Scale.
4. Children who required bilateral local anesthesia infiltration injections on primary or permanent teeth either in the maxilla or mandible for dental treatment (different types of restoration, stainless steel crowns, pulp therapy, and extractions).
5. Children with positive consent forms (signed and approved by their parents/ legal guardians) and attended the appointment.
Exclusion Criteria
2. Children who had a history of unpleasant experience with local anesthesia injection.
3. The presence of medically or developmentally compromising conditions.
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Jordan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lamis D. Rajab
Prof
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UJordanLamis
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.